DELPHARM POZNAN Revenue and Competitors
Estimated Revenue & Valuation
- DELPHARM POZNAN's estimated annual revenue is currently $40.6M per year.
- DELPHARM POZNAN's estimated revenue per employee is $201,000
Employee Data
- DELPHARM POZNAN has 202 Employees.
- DELPHARM POZNAN grew their employee count by 17% last year.
DELPHARM POZNAN's People
Name | Title | Email/Phone |
---|---|---|
1 | (Senior) QA Officer Product Release | Reveal Email/Phone |
2 | Facility Officer | Reveal Email/Phone |
3 | Head Finance | Reveal Email/Phone |
4 | Quality Assurance Officer Quality Control Labs | Reveal Email/Phone |
5 | Director Operational Excellence and Information Technology | Reveal Email/Phone |
6 | Finance Director | Reveal Email/Phone |
7 | Director HR | Reveal Email/Phone |
8 | Directeur de site / Site Director | Reveal Email/Phone |
9 | Director Quality Management | Reveal Email/Phone |
10 | Program Manager | Reveal Email/Phone |
DELPHARM POZNAN Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $9.2M | 92 | 42% | N/A | N/A |
#2 | $1.1M | 11 | 38% | N/A | N/A |
#3 | $23.9M | 119 | 5% | N/A | N/A |
#4 | $97.5M | 485 | 31% | N/A | N/A |
#5 | $18.3M | 91 | 40% | N/A | N/A |
#6 | $26.3M | 131 | 36% | N/A | N/A |
#7 | $35.2M | 175 | 50% | N/A | N/A |
#8 | $40.6M | 202 | 17% | N/A | N/A |
#9 | $1.9M | 19 | N/A | N/A | N/A |
#10 | $279.8M | 1392 | 12% | N/A | N/A |
What Is DELPHARM POZNAN?
Jesteśmy fabryką leków należącą do grupy Delpharm - topowego wytwórcy kontraktowego z branży farmaceutycznej. W codziennej pracy wykorzystujemy digitalizację i nowoczesne technologie, pamiętając o tym, że największą wartością naszej firmy są ludzie.
keywords:N/AN/A
Total Funding
202
Number of Employees
$40.6M
Revenue (est)
17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $53.7M | 215 | 23% | N/A |
#2 | $68.9M | 216 | 29% | N/A |
#3 | $27.6M | 228 | 18% | N/A |
#4 | $50.9M | 269 | 22% | N/A |
#5 | $87.4M | 274 | 25% | N/A |